Incyte Corp.Incyte Corp. witnessed a rebound after attempting to test the support level at 61.89, to close below the minor resistance 63.05, which is the level that needs to be violated to confirm the current positivity, which will trigger further rises near 62.65 - 65 - 65.61 - 66.43 - 67.40.
The stop-loss l
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.50 MXN
680.00 M MXN
88.43 B MXN
190.50 M
About Incyte Corporation
Sector
Industry
CEO
Herve Hoppenot
Website
Headquarters
Wilmington
Founded
1991
FIGI
BBG00PG38NC8
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
INCY - Incyte Bullish BreakoutOn this 5 Month Daily Chart of Incyte you can clearly see the Bearish Trend that included the last 6 weeks of each daily candle trending below the 7 Day EMA until just the last 2 trading days where the bottom was made and INCY finally broke above the 7 day EMA on very good strenth with much higher v
INCY Buy Opportunity "Pause Rebounders "Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Dem
WATCH $INCY CUP AND HANDLEBullish
Fundamental
- High inflationary Macro environment / still no fear form retail sentiment
- Decent Accumulation/Distribution
- Decent PE
- Decent PEG
- Decent P/FCF
- Top Sector / Industry
- Fundamental sound company with a Cup and handle play / short term
Technical
- Momentum Theory Indi
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where INCY is featured.
Related stocks
Frequently Asked Questions
The current price of INCY is 1,402.00 MXN — it has decreased by −8.37% in the past 24 hours. Watch INCYTE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange INCYTE CORPORATION stocks are traded under the ticker INCY.
We've gathered analysts' opinions on INCYTE CORPORATION future price: according to them, INCY price has a max estimate of 1,796.17 MXN and a min estimate of 1,015.23 MXN. Watch INCY chart and read a more detailed INCYTE CORPORATION stock forecast: see what analysts think of INCYTE CORPORATION and suggest that you do with its stocks.
INCY stock is 9.13% volatile and has beta coefficient of 0.35. Track INCYTE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is INCYTE CORPORATION there?
Today INCYTE CORPORATION has the market capitalization of 225.81 B, it has decreased by −5.40% over the last week.
Yes, you can track INCYTE CORPORATION financials in yearly and quarterly reports right on TradingView.
INCYTE CORPORATION is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
INCY earnings for the last quarter are 23.76 MXN per share, whereas the estimation was 20.04 MXN resulting in a 18.55% surprise. The estimated earnings for the next quarter are 27.27 MXN per share. See more details about INCYTE CORPORATION earnings.
INCYTE CORPORATION revenue for the last quarter amounts to 21.57 B MXN, despite the estimated figure of 20.18 B MXN. In the next quarter, revenue is expected to reach 22.50 B MXN.
INCY net income for the last quarter is 4.20 B MXN, while the quarter before that showed 2.10 B MXN of net income which accounts for 100.00% change. Track more INCYTE CORPORATION financial stats to get the full picture.
No, INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 29, 2025, the company has 2.62 K employees. See our rating of the largest employees — is INCYTE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE CORPORATION EBITDA is 3.53 B MXN, and current EBITDA margin is 3.99%. See more stats in INCYTE CORPORATION financial statements.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.